Ariumlab OÜ

14358662

Company info

Ariumlab OÜ

14358662

Home - Ariumlabhttp://ariumlab.com/Home - Ariumlab

Ariumlab designs, builds and markets solutions for life science and molecular diagnostics. Ariumlab is a brand of Glamarium OÜ, located in Tallinn, Estonia.

https://youtube.com/channel/UCWcWRDL8JtIFZaVXb5URYfw?reload=9https://linkedin.com/company/arium-labhttps://facebook.com/sharer/sharer.php?u=https://ariumlab.com/nucleic-acid-extraction-for-cancer-research/https://x.com/share?url=https://ariumlab.com/nucleic-acid-extraction-for-cancer-research/https://pinterest.com/pin/create/button/?url=https://ariumlab.com/nucleic-acid-extraction-for-cancer-research/&media=https://ariumlab.com/wp-content/uploads/2024/02/Nucleic-Acid-Extraction-for-Cancer-Research-v2.jpg&description=Nucleic+Acid+Extraction+for+Cancer+Researchhttps://linkedin.com/shareArticle?mini=true&url=https://ariumlab.com/nucleic-acid-extraction-for-cancer-research/https://api.whatsapp.com/send?text=https%3A%2F%2Fariumlab.com%2Fnucleic-acid-extraction-for-cancer-research%2Fhttps://facebook.com/sharer/sharer.php?u=https://ariumlab.com/nucleic-acid-extraction-techniques/https://x.com/share?url=https://ariumlab.com/nucleic-acid-extraction-techniques/https://pinterest.com/pin/create/button/?url=https://ariumlab.com/nucleic-acid-extraction-techniques/&media=https://ariumlab.com/wp-content/uploads/2024/01/ariumlab-dna-representation-collage.jpg&description=Nucleic+Acid+Extraction+Techniqueshttps://linkedin.com/shareArticle?mini=true&url=https://ariumlab.com/nucleic-acid-extraction-techniques/https://api.whatsapp.com/send?text=https%3A%2F%2Fariumlab.com%2Fnucleic-acid-extraction-techniques%2Fhttps://facebook.com/sharer/sharer.php?u=https://ariumlab.com/nucleic-acid-extraction-importance/https://x.com/share?url=https://ariumlab.com/nucleic-acid-extraction-importance/https://pinterest.com/pin/create/button/?url=https://ariumlab.com/nucleic-acid-extraction-importance/&media=https://ariumlab.com/wp-content/uploads/2024/01/Nucleic-Acid-Extraction-Importance.jpg&description=Nucleic+Acid+Extraction+Importancehttps://linkedin.com/shareArticle?mini=true&url=https://ariumlab.com/nucleic-acid-extraction-importance/https://api.whatsapp.com/send?text=https%3A%2F%2Fariumlab.com%2Fnucleic-acid-extraction-importance%2Fhttps://facebook.com/sharer/sharer.php?u=https://ariumlab.com/nucleic-acid-extraction-performance/https://x.com/share?url=https://ariumlab.com/nucleic-acid-extraction-performance/https://pinterest.com/pin/create/button/?url=https://ariumlab.com/nucleic-acid-extraction-performance/&media=https://ariumlab.com/wp-content/uploads/2024/01/Nucleic-Acid-Extraction-Performance-ariumlab.jpg&description=Nucleic+Acid+Extraction+Performancehttps://linkedin.com/shareArticle?mini=true&url=https://ariumlab.com/nucleic-acid-extraction-performance/https://api.whatsapp.com/send?text=https%3A%2F%2Fariumlab.com%2Fnucleic-acid-extraction-performance%2F+372%205354%200420

General info

Name

Ariumlab OÜ

Registry code

14358662

VAT number

EE102054844

Type

OÜ - Limited Liability Company

Status

Registered

Foundation date

24.10.2017 (7)

Financial year

01.01-31.12

Capital

2 500.00 €

Activity

7112 - Engineering activities and related technical consultancy 32509 - Manufacture of other medical and dental instruments and supplies 46699 - Wholesale of other general-purpose and special-purpose machinery, apparatus and equipment 62011 - Computer programming activities 74901 - Other professional, scientific and technical activities n.e.c.

Revenue

-

Profit

-

Profit margin

-

Gross salary

-

Equity

-

Employees

-

Annual report

-

Tax arrears

No tax arrears

Return on equity

-

Return on assets

-

Related parties

Owner Representative Beneficial owner Roles

Cem Türkmen

50% - 1 250.00 EUR Board member - Founder

Hanna Türkmen

50% - 1 250.00 EUR Board member - Founder

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q4 16 516.91 € 2 618.93 € 4 523.1 € 1
2024 Q3 79 530.44 € 3 993.02 € 4 655.6 € 1
2024 Q2 58 430.38 € 8 015.17 € 4 518.16 € 1
2024 Q1 104 703.05 € 8 185.28 € 4 371.17 € 1
2023 Q4 54 466.3 € 6 216.96 € 4 501.58 € 1
2023 Q3 41 751.05 € 4 148.05 € 4 440.66 € 1
2023 Q2 23 198.8 € 3 646.92 € 3 867.84 € 2
2023 Q1 32 924.57 € 2 018.04 € 3 092.28 € 1
2022 Q4 29 637.53 € 2 882.36 € 2 613.61 € 1
2022 Q3 29 033.1 € 2 473.08 € 2 385.6 € 2
2022 Q2 24 354.95 € 2 345.97 € 2 419.14 € 2
2022 Q1 374 261.15 € - 2 681.7 € 2
2021 Q4 126 932.36 € - 628.56 € 1
2021 Q3 3 863.47 € - 873.48 € -
2021 Q2 68 159.87 € 3 035.21 € 628.56 € 1
2021 Q1 12 037.94 € 2 018.62 € 605.24 € 2
2020 Q4 3 923.07 € 558.6 € 558.6 € 1
2020 Q3 1 653.64 € 537.97 € 558.6 € 1
2020 Q2 5 068.35 € 1 272.86 € 558.6 € 1
2020 Q1 -120.1 € 1 063.94 € 868.65 € 1